Dublin, May 09, 2022 (GLOBE NEWSWIRE) -- The "Automated External Defibrillator Market Research Report: By Type, Technology, Patient Type, End User - Global Industry Revenue Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.
The revenue of the automated external defibrillator market is projected to increase from an estimated $1,677.3 million in 2021 to $3,520.5 million by 2030, at an 8.6% CAGR.
According to the market research report the central factor behind it would be the increasing heart disease incidence due to genetic factors, aging, and poor lifestyle choices. Moreover, arrhythmias, which AEDs are designed to treat, aren't caused just by heart diseases themselves, but because of numerous pre-existing conditions.
Moreover, medical device companies are strengthening their efforts to advance the technology of these devices, to make them more accessible and easily usable for patients. For instance, the LifeVest, developed by ZOLL Medical Corporation, is a lightweight, wearable AED for those at a high risk of sudden cardiac arrest. Similarly, Philips's Tempus ALS is a defibrillator with remote monitoring functionality.
Apart from North America, the APAC region is witnessing a rise in the procurement of AEDs as the governments here are doing more than before to enhance their healthcare infrastructure. Additionally, the growing geriatric population is driving the incidence of all kinds of chronic diseases, which, ultimately, affect the heart. This is pushing up the installation of AEDs in hospitals, pre-hospital-care settings, and even primary-care clinics.
The biggest companies in the automated external defibrillator market are Koninklijke Philips N.V., Nihon Kohden Corporation, BIOTRONIK SE & Co. KG, SCHILLER AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Stryker Corporation, ZOLL Medical Corporation, CU Medical System Inc., and Mediana Co. Ltd. To gain a competitive edge, they are launching more-advanced wearable and non-wearable AEDs and acquiring similar companies.
The external defibrillator market, which generated an estimated revenue of $4,111.4 million in 2021, will witness an 8.7% CAGR, to reach $8,709.2 million by 2030. The key reason will be the geriatric population (65 years and above), which has been forecast by the UN to increase from 727 million in 2020 to 1.5 billion in 2050. Compared to younger people, the elderly are more prone to all kinds of diseases, especially CVDs.
Key Findings of Automated External Defibrillator Market Report
- Fully automatic AEDs are procured in the higher numbers because they are quicker to send the electrical pulse to correct the abnormal heart rhythm.
- Adults are the larger benefactors of the automated external defibrillator market because they, especially the elderly, are at a higher risk of arrhythmias than younger people.
- North America has the largest number of AEDs in public and private settings because of the advanced healthcare infrastructure here and higher general awareness on the benefit of these devices.
- Moreover, governments in the U.S. and Canada are taking initiatives at the federal, state/provincial, and county levels to install such life-saving equipment in public places.
- Therefore, the growing number of public-access defibrillators is a key trend in the automated external defibrillator market, as these devices save the time it takes for emergency personnel to arrive or patients to reach a medical facility.
- Along with this, regional governments are launching programs to train people on using such devices. Among the agencies taking part in such initiatives are the American Red Cross (ARC), Ozarks Technical Community College, AHA, Safety Council of the Ozarks, and CoxHealth.
Key Topics Covered:
Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.4 Key Stakeholders
Chapter 2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Baseline Methodology
2.4 Market Size Estimation
2.5 Data Triangulation
2.6 Assumptions for the Study
Chapter 3. Executive Summary
Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 by Type
4.1.1.1 Non-Wearable
4.1.1.2 Wearable
4.1.2 by Technology
4.1.2.1 Fully Automatic
4.1.2.2 Semi-Automatic
4.1.3 by Patient Type
4.1.3.1 Adult
4.1.3.2 Pediatric
4.1.4 by End-user
4.1.4.1 Pre-Hospital Care and Ems Providers
4.1.4.2 Public Access Settings
4.1.4.3 Homecare Settings
4.1.4.4 Hospitals, Clinics, and Cardiac Centers
4.1.4.5 Others
4.2 Market Dynamics
4.2.1 Trends
4.2.1.1 Growing Focus on Installation of AEDs in Public Places
4.2.1.2 Shifting Focus from Implantable Devices to External Defibrillators
4.2.1.3 Increasing Number of Product Launches
4.2.2 Drivers
4.2.2.1 Advancements in AED Technology
4.2.2.2 Surging Geriatric Population
4.2.2.3 Increasing Number of Strategic Developments Among Key Players
4.2.2.4 Rising Incidence of Cardiac Diseases
4.2.2.5 Impact Analysis of Drivers on Market Forecast
4.2.3 Restraints
4.2.3.1 Product Failures
4.2.3.2 Stringent Regulatory Norms
4.2.3.3 Impact Analysis of Restraints on Market Forecast
4.2.4 Opportunities
4.2.4.1 Awareness and Training Programs on Defibrillation
4.3 Porter's Five Forces Analysis
4.4 Regulatory Scenario for AEDs
4.5 Reimbursement Policies
4.6 Impact of Covid-19
Chapter 5. Global Market Size and Forecast
5.1 by Type
5.2 by Technology
5.3 by Patient Type
5.4 by End-user
5.5 by Region
Company Profiles
- Koninklijke Philips N.V.
- Biotronik Se & Co. Kg
- Nihon Kohden Corporation
- Schiller AG
- Stryker Corporation
- Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
- Zoll Medical Corporation
- Mediana Co. Ltd.
- Cu Medical System Inc.
For more information about this report visit https://www.researchandmarkets.com/r/4ol0wh
Attachment
